What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to disclose HCA Holdings, Inc.'s entry into a material definitive agreement to refinance its existing senior secured term B-6 loan credit facility with a new $1.489 billion senior secured term B-9 loan credit facility. This is a debt refinancing transaction.

What are the key terms of the new $1.489 billion senior secured term B-9 loan credit facility?

The new facility matures on March 18, 2023, similar to the old one. Interest rates will be based on either LIBOR plus a 2.00% applicable margin or a base rate plus a 1.00% applicable margin. Amortization payments are set at 0.25% payable at the end of each fiscal quarter starting June 30, 2017. A 1.00% prepayment premium will be incurred for repricing transactions within the first six months of the facility's effectiveness.

How does this refinancing impact HCA's financial obligations?

This transaction creates a new direct financial obligation for HCA Inc. and HCA Holdings, Inc. (as guarantor). While the maturity date remains the same, the specific interest rate structure and amortization schedule have been updated. Investors should note the potential for slightly different borrowing costs and the terms related to early repayment.

Who are the key parties involved in this new loan facility?

The key parties involved include HCA Inc. as the borrower, the guarantors of the loan, Bank of America, N.A. as the administrative agent and collateral agent, and the lenders party to the agreement.

HCA 8-K: Material Agreements & Financial Events

Summary

This 8-K filing from HCA Holdings, Inc. (HCA) on March 20, 2017, details a significant debt refinancing transaction. The company, through its subsidiary HCA Inc., entered into a joinder agreement to replace its existing senior secured term B-6 loan credit facility with a new $1.489 billion senior secured term B-9 loan credit facility. This move is primarily aimed at refinancing existing debt that was maturing in March 2023, with the new facility also maturing on the same date. While the terms are largely similar, investors should note the specific interest rate structure (LIBOR plus a 2.00% margin or a base rate plus a 1.00% margin) and the new amortization schedule (0.25% per fiscal quarter). Additionally, a 1.00% prepayment premium will apply to repricing transactions within the first six months of the new facility's effective date. This refinancing indicates proactive debt management by HCA to ensure continued access to capital and potentially optimize borrowing costs.

Key Highlights

1HCA Holdings, Inc. refinanced its senior secured term B-6 loan credit facility through its subsidiary HCA Inc.
2A new $1.489 billion senior secured term B-9 loan credit facility was established.
3The new facility matures on March 18, 2023, matching the maturity of the refinanced debt.
4Interest rates on the new facility are LIBOR plus a 2.00% margin or a base rate plus a 1.00% margin.
5Amortization payments for the new facility are set at 0.25% of the principal amount per quarter.
6A 1.00% prepayment premium applies to repricing transactions within six months of the agreement's effective date.
7This transaction is classified as a material definitive agreement and the creation of a direct financial obligation.

HCA Healthcare, Inc. 8-K Report, Material Agreement (Mar 20, 2017)

Summary

Key Highlights

Frequently Asked Questions